Is MaxCyte (MXCT) stock Halal?

MaxCyte is a biotechnology company that specializes in developing advanced cell engineering technology used across the biomedical industry. At the core of the company's operations is its proprietary electroporation platform, which enables precise, efficient, and scalable modifications of cells. This technology is pivotal for research and development in gene editing, cell therapy, and immune-oncology, fields that are rapidly evolving and gaining significance in the fight against various diseases, including cancer. For Muslim investors, though, the most pressing question is simpler: is MaxCyte a Halal investment?

Is MaxCyte Shariah compliant?

No. In the October 2026 screening MaxCyte (MXCT) does not pass AAOIFI screening: it fails the non-permissible income and interest-bearing investments screens. Medicines and medical devices are permissible, and healthcare companies like MaxCyte usually clear the activity screen comfortably. What AAOIFI Shariah Standard No. 21 watches is the financing behind the pipeline: drug development is expensive, and the 30% interest bearing debt cap decides the verdict more often than the science does.

Does MaxCyte pass the business activity test?

The activity screen is only part of the picture this month: MaxCyte currently fails the non-permissible income and interest-bearing investments screens, so the overall verdict is not compliant regardless of the business itself. Treating illness is permissible work; the scrutiny belongs to the financing behind it.

Is MaxCyte's income Halal?

No. MaxCyte's income from impermissible sources currently exceeds AAOIFI's 5% revenue ceiling, which makes the stock non-compliant on this screen regardless of the others. The screen is reassessed monthly, so the status can change when new financial statements arrive.

Does MaxCyte meet AAOIFI's debt and investment ratio requirements?

Not in full. Interest bearing investments currently exceed the 30% cap, measured against a market capitalisation of $116M (market data as of 1 October 2026), while the other ratio stays within it. One breach is enough to fail the screening; the ratios are reassessed monthly under our Shariah Supervisory Board.

Why do other halal screeners show a different verdict for MaxCyte?

Screeners can disagree without either being wrong. AAOIFI Shariah Standard No. 21, which Tabadulat applies, measures interest bearing debt and investments against market capitalisation with a 30% ceiling. MSCI and FTSE measure them against total assets with a 33% ceiling, and S&P and Dow Jones Islamic use a multi year average of market capitalisation. Data dates differ too, because each provider reads filings and prices on its own schedule. The same company can therefore pass one standard and fail another in the same month. Tabadulat publishes one answer, the AAOIFI result as of October 2026, and re-screens it every month.

Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.

New to the screening method? Read What is Halal Investing? A Guide to Halal Stocks and Islamic Finance